Optimizing Cancer Treatment: Exploring the Role of AI in Radioimmunotherapy

Optimizing Cancer Treatment: Exploring the Role of AI in Radioimmunotherapy

Radioimmunotherapy (RIT) is a novel cancer treatment that combines radiotherapy and immunotherapy to precisely target tumor antigens using monoclonal antibodies conjugated with radioactive isotopes. This approach offers personalized, systemic, and durable treatment, making it effective in cancers re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hossein Azadinejad, Mohammad Farhadi Rad, Ahmad Shariftabrizi, Arman Rahmim, Hamid Abdollahi
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Diagnostics
Subjects:	radioimmunotherapy cancer treatment personalized medicine monoclonal antibodies
Online Access:	https://www.mdpi.com/2075-4418/15/3/397
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
by: V. I. Chernov, et al.
Published: (2016-07-01)

Experimental and clinical approaches to a radioimmunotherapy in o
by: E. V. Abakushina, et al.
Published: (2016-02-01)

Radioimmunotherapy combating biofilm-associated infection in vitro
by: Zijian Ye, et al.
Published: (2024-11-01)

An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma Radioimmunotherapy
by: Cheng Chen, et al.
Published: (2025-08-01)

Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8+ T cell depletion
by: Connor Frank, et al.
Published: (2025-07-01)

Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
by: Ziting Xu, et al.
Published: (2025-07-01)

Tumor microenvironment modulation by SERPINE1 increases radioimmunotherapy in murine model of gastric cancer
by: Javeria Zaheer, et al.
Published: (2025-05-01)

A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (9C4)
by: Naiim S. Ali, et al.
Published: (2019-01-01)

Pneumonitis after normofractionated radioimmunotherapy: a method for dosimetric evaluation
by: Kim Melanie Kraus, et al.
Published: (2024-11-01)

Antibody conjugates in neuroblastoma: a step forward in precision medicine
by: Jihane Balla, et al.
Published: (2025-03-01)

DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC
by: Chen L, et al.
Published: (2025-03-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01)

Radionuclide teranostic of malignancies
by: V. I. Chernov, et al.
Published: (2016-11-01)

Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials
by: Marco Piscaglia, et al.
Published: (2025-07-01)

Current concepts of radioimmonotherapy for lymphoma
by: Mihailović Jasna, et al.
Published: (2015-01-01)

Migraine treatment: the doors for the future are open, but with caution and prudence
by: Abouch V. Krymchantowski, et al.

Potential of non-FDG PET radiotracers for paediatric patients with solid tumours
by: Leonor Teles, et al.
Published: (2024-12-01)

Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment
by: Razvan Constantin Vonica, et al.
Published: (2025-03-01)

From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors
by: David Kryza, et al.
Published: (2023-03-01)

Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
by: Rose Ghemrawi, et al.
Published: (2024-09-01)

Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery
by: Elnazalsadat Jafarzadeh Chehraghi, et al.
Published: (2025-04-01)

Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody
by: Yuki Majima, et al.
Published: (2025-06-01)

Experience in using specific recombinant monoclonal antibodies in comorbid patients with coronavirus infection
by: S. A. Sokotun, et al.
Published: (2024-12-01)

The long-term remission of rheumatoid arthritis with a single cycle of rituximab
by: Glišić Branislava, et al.
Published: (2012-01-01)

Case Report: Efficacy of ofatumumab in refractory anti-NMDAR encephalitis: case series and literature review
by: Min Deng, et al.
Published: (2025-03-01)

A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
by: Angel Justiz-Vaillant, et al.
Published: (2025-04-01)

Recommendations for the prevention of respiratory syncytial virus in high-risk pediatric groups
by: Janković Borisav, et al.
Published: (2009-01-01)

Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01)

Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01)

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
by: Emiel A. De Jaeghere, et al.
Published: (2022-08-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates
by: Ami Patel, et al.
Published: (2024-12-01)

EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitis
by: Michael J. Rudy, et al.
Published: (2025-04-01)

Circulating Antibody’s Role During Post-Exposure Prophylaxis, and Beyond for Rabies: A Review
by: Qingjun Chen, et al.
Published: (2025-07-01)

Application of Monoclonal Antibodies against Naturally Occurring Bioactive Ingredients
by: Shunsuke Fujii, et al.
Published: (2024-07-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

The Research Progress of Monoclonal Antibody Labeled with 89Zr
by: Zhanxiong XIAO, et al.
Published: (2025-04-01)

Production and application of monoclonal antibodies to GST
by: WU Jian-xiang, et al.
Published: (2006-07-01)

How to use monoclonal antibody-based therapy in ALL
by: Erica Brivio, et al.
Published: (2025-06-01)